Rayner continues growth in Europe with direct presence in Italy

Posted on 6/07/2016

For immediate release

Date: 6th July, 2016

Rayner continues growth in Europe with direct presence in Italy

Rayner is pleased to announce its direct entry into the Italian cataract market.

The entire Rayner IOL & injector portfolio, available in Italy for the last 20 years via independent distributors, is now available through Rayner Italia Srl.

Incorporated in Milan, Rayner Italia includes a growing team of experienced Ophthalmic Specialist Area Managers, who are focussed on delivering the highest levels of service and support.

General Manager, James Crutchlow, commented that “following the 2014 acquisition of Rayner Surgical GmbH (our exclusive distributor in Germany and Austria), Rayner Italia Srl expands our direct presence into Europe’s third largest cataract market”.

What does this mean for surgeons?
Rayner Italia Srl will work closely with surgeons in Italy to provide access to Rayner’s latest technologies during a significant period of new product development. This includes the pending launch of RayOne; our fully preloaded IOL injection system due to be presented at the 2016 ESCRS in Copenhagen.

Through being closer to Rayner’s extensive portfolio, Rayner Italia offers comprehensive training and education as well as highly responsive delivery times.

Simonetta Morselli MD, San Bassano Hospital, Italy, commented “We are very pleased that Rayner has entered the Italian market. Rayner has a strong heritage in developing the world’s first IOL, and we are excited about the opportunity to work directly with them”.

Rayner’s recent move to The Ridley Innovation Centre  —  with its trebled production capacity — will support our ambitious plans to expand our direct salesforce/business throughout Europe.


About Rayner

Rayner designs and manufactures intraocular lenses (IOLs) and proprietary injection devices for use in cataract surgery. As the first manufacturer of the IOL, we have been working with surgeons for longer than anyone. Today, we exist to enable surgeons to focus on what matters: improving patient’s sight. We aim to remain at the forefront of innovation, developing clinically superior ophthalmic tools that aid and streamline the surgical process, with the ultimate objective of improving sight and quality of life.

Rayner markets its IOL portfolio and related products worldwide through a network of distributors in over 80 countries and a direct sales team in the United Kingdom, USA, Germany & Austria and Italy.

For questions or to schedule an interview with a Rayner representative, please contact Rayner: iol_enquiries@rayner.com

Not all Rayner products are approved for sale in every country. Please contact your local Rayner distributor for details of which products are available in your area.
©2016 Rayner Intraocular Lenses Limited. RayOne is a registered trademark of Rayner.

Share this article